Results 251 to 260 of about 113,461 (351)

A Surface Plasmon Resonance‐Based Integrated Assay for Quantification and Glycosylation Characterization of Monoclonal Antibodies in Crude Heterogeneous Samples

open access: yesBiotechnology and Bioengineering, Volume 122, Issue 10, Page 2724-2738, October 2025.
ABSTRACT The rise in cancer, autoimmune, inflammatory, and infectious diseases in recent decades has led to a surge in the development of monoclonal antibodies (mAbs) therapies, now the most widely used family of biologics. To meet the growing global demand, biopharmaceutical industries are intensifying their production processes.
Ilona Metayer   +7 more
wiley   +1 more source

Integrated SegFlow, µSIA, and UPLC for Online Sialic Acid Quantitation of Glycoproteins Directly from Bioreactors. [PDF]

open access: yesEng Life Sci
Chemmalil L   +12 more
europepmc   +1 more source

Peptide Modulation Overrides Glycan Synergy in Gold Nanoparticle‐Based Vaccines for Cancer Immunotherapy

open access: yesCancer Medicine, Volume 14, Issue 19, October 2025.
This study explores how antigen peptides and sugar chains affect the efficacy of glyco‐nanovaccines (iGN) in cancer immunotherapy. We show that antigen peptides, rather than sugar chains, are key to nanoparticle uptake and immune activation, with sialic acid‐modified iGN showing similar anti‐cancer efficacy to α‐mannose‐modified iGN in a mouse model ...
Narumi Harada   +10 more
wiley   +1 more source

The studies on sialic acid of platelets

open access: bronze, 1977
Koneo YAMADA   +3 more
openalex   +2 more sources

Estrogen Modulation of B Cell Immunity: Implications for HIV Control and Therapeutic Strategies

open access: yesComprehensive Physiology, Volume 15, Issue 5, October 2025.
Estrogen significantly modulates B‐cell immunity. We provide evidence for estrogen–B‐cell crosstalk (the estrogen–B‐cell axis) in regulating B‐cell function and shaping HIV acquisition, progression, and persistence, and highlight research gaps to guide hormone‐aware vaccines and therapies.
John Kasibante   +3 more
wiley   +1 more source

Dysbiosis-associated gut bacterium <i>Ruminococcus gnavus</i> varies at the strain level in its ability to utilize key mucin component sialic acid. [PDF]

open access: yesMicrobiol Spectr
Sokolovskaya OM   +8 more
europepmc   +1 more source

Characterization of Proteomic Pharmacodynamic Biomarkers of IFNβ‐1a Biologics to Inform Potential Utility in Biosimilar Development

open access: yesClinical Pharmacology &Therapeutics, Volume 118, Issue 4, Page 935-945, October 2025.
Pharmacodynamic (PD) biomarkers can support biosimilarity assessment, potentially reducing the need for comparative clinical efficacy studies. This study aimed to characterize previously identified proteomic PD biomarker candidates for Interferon beta‐1a (IFNβ‐1a, n = 248) and pegylated IFNβ‐1a (pegIFNβ‐1a, n = 528) biologics at therapeutic doses, to ...
Lakshmi Manasa S. Chekka   +15 more
wiley   +1 more source

Home - About - Disclaimer - Privacy